Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $1.4B bought by 293 insiders at 194 companies
- $6.3B sold by 282 insiders outside a trading plan
- $3.3B sold by 627 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past 3 months · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$595M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$124M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$115M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.5M
-
GMEGameStop CorporationRyan CohenCEO$54M
-
GRABGrab Holdings LimitedAnthony Ping Yeow TanCEO$29.9M
-
GSATGlobalstar, Inc.James Monroe IIIDirector$29.8M
-
COURCoursera, Inc.Pale Fire Capital SE10% owner · +4 joint filers$11.4M
-
CVCapsoVision, Inc.Eliyahou Et Al Harari10% owner$10M
Biggest sales
Past 3 months · by insider, all their filings added up · planned sales marked
-
FANGDiamondback Energy, Inc.SGF FANG Holdings, LP10% owner · +1 joint filer$3.7B
-
IHTInnSuites Hospitality TrustMarc E BergEVP & Secretary/Treasurer$361M
-
NVDANvidia Corporation ComMark A StevensDirector$300M
-
AVGOBroadcom Inc.Henry SamueliDirector$250M
-
UMCUnited Microelectronics CorporationChitung LiuCFO$229M
-
THTarget Hospitality Corp.TDR Capital II Investments LP10% owner · +9 joint filers$202M
-
AURAurora Innovation, Inc.Uber Technologies, Inc10% owner$182M
-
ESTCElastic N.V.Steven SchuurmanDirector$135M
-
CRWDCrowdStrike Holdings, Inc.Burt W. PodbereCFO$134M
-
MEDPMedpace Holdings, Inc.August J. TroendleCEO$126M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Thomas Jon Hammond Director, Sandip I Patel CFO, John Martin Schaible Chair, David Craig Ridenhour President, +1 more
-
John B Williamson III Director, Robert B Johnston Director, Paul W Nester CEO, Lawrence T. Oliver Senior VP and Secretary, +1 more
-
Matthew G De Soto Director, Albert J. Evans Director, Kimberly J Brumbaugh Director, Theodore W Mowery Director, +1 more
-
Alexandros Pappas Insider, Raffaele Zagari Director, Nikolaos Reskos COO, Charis Plakantonaki Chief Strategy Officer
-
Joseph D Sarafa Director, Brian J Roney CEO, Isolde O'Hanlon Director, Harold J Meloche CFO
-
Lewis H Titterton Jr. Director, Amit Kumar CEO, Michael Catelani CFO, Arnold M Baskies Director
-
Michael Jordan Osborn CEO, Gregory William Voorhies Director, Chris Riccardi Director, James W Bernau President
-
J Tutt Barrett Director, David E Housel Director, William F Ham Jr. Director, Shannon O'Donnell Senior Vice President
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
Marcus Lemonis CEONXHNeighborhood Intelligence, Inc.Buy$1M 362,319 shares at $2.76 +51% to stakeTraded Oct 6 Filed Oct 6
-
Kun Dai CEOUXINUxin LimitedBuy$11K 8,683 shares at $1.27 +28% to stakeTraded Oct 5 Filed Oct 6
-
Andrew Little Thompson CEORIMEAlgorhythm Holdings, Inc.Buy— 4,076,312 shares New stakeTraded Sep 15 Filed Oct 5
-
Michael Kliger CEOLUXELuxExperience B.V.Sale$766K 76,008 shares at $10.08 100% of stakeTraded Oct 1–2 Filed Oct 5
-
William O'Dowd IV CEODLPNDolphin Entertainment, Inc.Buy$4,856 4,500 shares at $1.08 +0.8% to stakeTraded Oct 5 Filed Oct 5
-
Sanjeev Aggarwal CEOMRAMEverspin Technologies, Inc.Sale$373K 19,572 shares at $19.08 2.3% of stakeTraded Oct 2 Filed Oct 5
-
Michael Jordan Osborn CEOWVVIWillamette Valley Vineyards, Inc.Buy$19K 10,000 shares at $1.91 +50% to stakeTraded Oct 2 Filed Oct 5
-
Kun Dai CEOUXINUxin LimitedBuy$7,323 5,672 shares at $1.29 +23% to stakeTraded Oct 2 Filed Oct 5
-
Brett Alan Cope CEOPOWLPowell Industries, Inc.Sale$901K 4,799 shares at $187.67 0.9% of stakeTraded Sep 30 Filed Oct 2
-
Amit Gupta CEOCDLXCardlytics, Inc.Sale$47K 17,733 shares at $2.64 11% of stakeTraded Oct 1–2 Filed Oct 2
-
Ryan Cohen CEOGMEGameStop CorporationBuy$17.1M 700,000 shares at $24.41 +1.7% to stakeTraded Oct 2 Filed Oct 2
-
Conor Murphy CEOFGF&G Annuities & Life, Inc.Buy$5,015 231 shares at $21.68 +0.1% to stakeTraded Sep 30 Filed Oct 2
-
Kun Dai CEOUXINUxin LimitedBuy$13K 9,000 shares at $1.42 +57% to stakeTraded Oct 1 Filed Oct 2
-
Satish Dhanasekaran CEOKEYSKeysight Technologies Inc.Sale$1.1M 3,000 shares at $364.13 2.5% of stakeTraded Sep 30 Filed Oct 2
-
August J. Troendle CEOMEDPMedpace Holdings, Inc.Sale$30.3M 48,667 shares at $623.03 13% of stakeTraded Sep 29–30 Filed Oct 1
-
Brian J Roney CEOPRHIPresurance Holdings, Inc.Buy$51K 7,500 shares at $6.75 +10% to stakeTraded Sep 30 Filed Oct 1
-
Cesar Nivaldo Gon CEOCINTCI&T IncBuy$20K 6,684 shares at $3.01 +8.9% to stakeTraded Sep 29–30 Filed Oct 1
-
William Staples CEOGTLBGitLab Inc.Buy$125K 2,677 shares at $46.62 +0.4% to stakeTraded Sep 30 Filed Oct 1
-
Glen R Ives CEOCTMCastellum, Inc.Buy$910 1,700 shares at $0.5400 +0.8% to stakeTraded Oct 1 Filed Oct 1
-
Alejandro Gustavo Elsztain CEOCRESYCresud S.A.C.I.F. y A.Buy$199K 17,334 shares at $11.50 +1.4% to stakeTraded Sep 30–Oct 1 Filed Oct 1
-
Ian Mortimer CEOXENEXenon Pharmaceuticals Inc.Buy$1.1M 30,000 shares at $37.38 +151% to stakeTraded Sep 30 Filed Oct 1
-
Richard Barry CEOFLNAFilana Therapeutics, Inc.Buy$278K 306,813 shares at $0.9100 +30% to stakeTraded Sep 29–30 Filed Oct 1
-
Kun Dai CEOUXINUxin LimitedBuy$9,945 7,443 shares at $1.34 +88% to stakeTraded Sep 30 Filed Oct 1
-
Peter Altman CEOBCDABioCardia, Inc.Buy$1,030 1,000 shares at $1.03 +0.3% to stakeTraded Sep 29 Filed Sep 30
-
John Taylor Maloney Fitzgerald CEOKWYKingsway CorporationBuy$2,502 269 shares at $9.30 +<0.1% to stakeTraded Sep 30 Filed Sep 30
-
William B. Horne CEOGPUSHyperscale Data, Inc.Buy$16K 100,000 shares at $0.1600 +25% to stakeTraded Sep 30 Filed Sep 30
-
Richard Barry CEOFLNAFilana Therapeutics, Inc.Buy$78K 93,091 shares at $0.8400 +9.9% to stakeTraded Sep 28 Filed Sep 30
-
Kevin J McNamara CEOCHEChemed Corp.Sale$1M 2,000 shares at $513.45 2.9% of stakeTraded Sep 28 Filed Sep 30
-
Richard H Moore CEOFBNCFirst BancorpSale$1.5M 23,343 shares at $62.85 22% of stakeTraded Sep 28–29 Filed Sep 30
-
Robert George Culp IV CEOCULPCulp, Inc.Buy$12K 2,960 shares at $3.89 +2.2% to stakeTraded Sep 28 Filed Sep 30
-
Kun Dai CEOUXINUxin LimitedBuy$11K 8,440 shares at $1.26 New stakeTraded Sep 29 Filed Sep 30
-
Joseph P. Davy CEOPARABanzai International, Inc.Buy— 115,965 shares +343% to stakeTraded Sep 28 Filed Sep 30
-
Michael Edell CEOSNESSenesTech, Inc.Buy$1,289 2,000 shares at $0.6400 +22% to stakeTraded Sep 28 Filed Sep 29
-
Ryan Cohen CEOGMEGameStop CorporationBuy$10.6M 450,000 shares at $23.48 +1.1% to stakeTraded Sep 29 Filed Sep 29
-
William B. Horne CEOGPUSHyperscale Data, Inc.Buy$17K 100,000 shares at $0.1700 +33% to stakeTraded Sep 29 Filed Sep 29
-
August J. Troendle CEOMEDPMedpace Holdings, Inc.Sale$1.6M 2,564 shares at $620.10 0.7% of stakeTraded Sep 25–28 Filed Sep 29
-
Ross Dove CEOHGBLHeritage Global Inc.Sale$399K 300,000 shares at $1.33 13% of stakeTraded Sep 25 Filed Sep 29
-
Yongdong Peng CEOBEKEKE Holdings IncSale$84.6M 16M shares at $5.27 20% of stakeTraded Sep 25 Filed Sep 29
-
Mark Lappe CEOINBXInhibrx Biosciences, Inc.Buy$999K 10,000 shares at $99.88 +1.4% to stakeTraded Sep 25–28 Filed Sep 28
-
Benjamin J Bochnowski CEOFNWDFinward BancorpBuy$224 5 shares at $43.48 +0.3% to stakeTraded Sep 25 Filed Sep 28
-
William O'Dowd IV CEODLPNDolphin Entertainment, Inc.Buy$4,884 4,400 shares at $1.11 +0.8% to stakeTraded Sep 28 Filed Sep 28
-
Amit Kumar CEOANIXAnixa Biosciences, Inc.Buy$19K 7,000 shares at $2.78 +1.1% to stakeTraded Sep 24 Filed Sep 28
-
Jennifer Jarrett CEODMRADamora Therapeutics, Inc.Buy$253K 12,500 shares at $20.23 +2.5% to stakeTraded Sep 25 Filed Sep 28
-
August J. Troendle CEOMEDPMedpace Holdings, Inc.Sale$27.4M 43,916 shares at $624.01 10% of stakeTraded Sep 23–24 Filed Sep 25
-
Ronald W Hovsepian CEOSKILSkillsoft Corp.Buy$66K 11,196 shares at $5.93 +3% to stakeTraded Sep 23 Filed Sep 25
-
Douglas Love CEOANNXAnnexon, Inc.Buy$100K 26,065 shares at $3.83 +7.2% to stakeTraded Sep 24 Filed Sep 25
-
Chae Lee CEOMXMagnachip Semiconductor CorporationBuy$318K 100,000 shares at $3.18 +35% to stakeTraded Sep 23–24 Filed Sep 25
-
Paul W Nester CEORGCORGC Resources Inc.Buy$6,324 300 shares at $21.08 +0.2% to stakeTraded Sep 23 Filed Sep 25
-
Thomas Caldecot Chubb III CEOOXMOxford Industries, Inc.Buy$65K 2,500 shares at $26.15 +7.4% to stakeTraded Sep 24 Filed Sep 24
-
Jonathan Shar CEOBNEDBarnes & Noble Education, IncSale$331K 30,000 shares at $11.04 8.4% of stakeTraded Sep 22 Filed Sep 24
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,792 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.